RT Journal Article
SR Electronic
T1 Demographic and genetic factors shape the epitope specificity of the human antibody repertoire against viruses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.07.23298153
DO 10.1101/2023.11.07.23298153
A1 Olin, Axel
A1 Jaquaniello, Anthony
A1 Roux, Maguelonne
A1 Tan, Ziyang
A1 Pou, Christian
A1 Dubois, Florian
A1 Charbit, Bruno
A1 Liu, Dang
A1 Bloch, Emma
A1 Clave, Emmanuel
A1 Araujo, Itauá Leston
A1 Toubert, Antoine
A1 White, Michael
A1 Rotival, Maxime
A1 Brodin, Petter
A1 Duffy, Darragh
A1 Quintana-Murci, Lluis
A1 Patin, Etienne
A1 Milieu Intérieur Consortium
YR 2024
UL http://medrxiv.org/content/early/2024/11/20/2023.11.07.23298153.abstract
AB Antibodies are central to immune defenses. Despite advances in understanding the mechanisms of antibody generation, a comprehensive model of how intrinsic and external factors shape human humoral responses to viruses is lacking. Here, we apply PhIP-Seq to investigate the effects of demographic and genetic factors on antibody reactivity to more than 97,000 viral peptides in 1,212 healthy adults. We demonstrate that age, sex, and continent of birth extensively influence the viruses and viral epitopes targeted by the human antibody repertoire. Among 108 lifestyle and health-related variables, smoking exerts the strongest, yet reversible, impact on antibody profiles, primarily against rhinoviruses. Additionally, we identify strong associations between antibodies against 34 viruses and genetic variants at HLA, FUT2, IGH, and IGK genes, some of which increase autoimmune disease risk. These findings offer a valuable resource for understanding the factors affecting antibody-mediated immunity, laying the groundwork for optimizing vaccine strategies.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.milieuinterieur.fr/en/ Funding StatementThe study received funding from the Wenner-Gren Foundation and benefited from the support of the French government program Investissement d'Avenir, managed by the Agence Nationale de la Recherche (reference 10-LABX-69-01).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institut Pasteur (Pasteur ID-RCB Number:2012-A00238-35), the Comités de Protection des Personnes, Ouest 6 and Sud Méditerranée (CPP), the Agence Nationale de Sécurité du Médicament (ANSM) and the Commission nationale de l'informatique et des libertés (CNIL) gave ethical approval for the Milieu Intérieur clinical study and this work. The ethics committee of Ghent University (B670201214647), the Ethics Board of Institut Pasteur (EVOIMMUNOPOP-281297), the Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé (CCITRS), the CPP and the CNIL gave ethical approval for the EvoImmunoPop study and this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe VirScan3 PhIP-seq raw and processed data generated in this study have been deposited in the Institut Pasteur data repository, OWEY, which can be accessed via the following link: https://dataset.owey.io/doi/10.48802/owey.84rn-jg72?version=1.1. All association statistics obtained in this study can be explored and downloaded from the web browser http://mirepertoire.pasteur.cloud/. The SNP array data can be accessed in the European Genome-Phenome Archive (EGA) with the accession code EGAS00001002460. All Milieu Intérieur datasets can be accessed by submitting a data access request to milieuinterieurdac{at}pasteur.fr, the Milieu Intérieur data access committee (DAC). The DAC informs all the research participants of the data access request and grants data access if the request is consistent with the informed consent signed by the participants. In particular, research on Milieu Intérieur datasets is restricted to research on the genetic and environmental determinants of human variation in immune responses. Data access is typically granted two months after request submission.